Can mirikizumab mend the gut? new trial aims for deep healing in Crohn's

NCT ID NCT07292012

First seen Jan 11, 2026 · Last updated Jun 13, 2026 · Updated 24 times

Summary

This study tests if the drug mirikizumab can heal damage deep in the gut wall in people with Crohn's disease. About 75 adults with active symptoms and inflammation seen on MRI will receive the drug. The main goal is to see if the gut shows at least 25% improvement after 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH de Valence

    NOT_YET_RECRUITING

    Valence, 26000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Brest - Hôpital de la Cavale Blanche

    NOT_YET_RECRUITING

    Brest, 29200, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Clermont Ferrand - Hôpital d'Estaing

    RECRUITING

    Clermont-Ferrand, 63003, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Nîmes Carémeau

    NOT_YET_RECRUITING

    Nîmes, 30029, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Toulouse - Hôpital Rangueil

    NOT_YET_RECRUITING

    Toulouse, 31059, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Mutualiste Monsouris

    NOT_YET_RECRUITING

    Paris, 75674, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.